Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00403832
Recruitment Status : Completed
First Posted : November 27, 2006
Last Update Posted : July 28, 2010
Sponsor:
Information provided by:
St. Franziskus Hospital

Brief Summary:
Cataract is a common complication in uveitis patients. Cataract operations with intraocular lens implantation are difficult in these patients because of complication due to the biocompatibility of the intraocular lens. In this study, uveal and capsular biocompatibility of two widely used acrylate intraocular lenses are compared.

Condition or disease Intervention/treatment Phase
Uveitis Cataract Device: intraocular lenses: Two foldable, acrylic, sharp edged IOLs: AcrySof™ (AcrySof SA60AT, Alcon), and Akreos adapt™ (Bausch & Lomb) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of Two Different Acrylate Intraocular Lenses in Cataract Surgery in Patients With Non-infectious Uveitis
Study Start Date : August 2005
Study Completion Date : February 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract




Primary Outcome Measures :
  1. visual acuity
  2. cell deposits on anterior IOL surface
  3. posterior capsular opacification


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non infectious uveitis
  • no active inflammation
  • significant visual disturbance related to lens opacification

Exclusion Criteria:

  • vitreous opacification
  • ocular hypertension/glaucoma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00403832


Locations
Layout table for location information
Germany
Department of Ophthalmology at St.-Franziskus Hospital
Münster, Germany, 48145
Sponsors and Collaborators
St. Franziskus Hospital
Investigators
Layout table for investigator information
Principal Investigator: Arnd Heiligenhaus, Md Phd Department of Ophthalmology at St.-FranziskusHospital Münster
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00403832    
Other Study ID Numbers: 05-2911
First Posted: November 27, 2006    Key Record Dates
Last Update Posted: July 28, 2010
Last Verified: August 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Cataract
Uveitis
Lens Diseases
Eye Diseases
Uveal Diseases